Detalhe da pesquisa
1.
Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
Molecules
; 28(16)2023 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37630292
2.
The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.
Prostate
; 82(13): 1237-1247, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675470
3.
Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.
Support Care Cancer
; 30(3): 2803-2810, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845502
4.
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity.
Cancer
; 127(15): 2631-2640, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882144
5.
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.
J Urol
; 205(5): 1361-1371, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356529
6.
Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen.
J Pharmacol Exp Ther
; 374(3): 438-451, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554434
8.
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
Prostate
; 76(3): 286-93, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493492
10.
The pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cells.
Prostate
; 74(15): 1530-43, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25175748
11.
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Cancer
; 120(10): 1491-8, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523016
12.
Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.
J Transl Med
; 12: 313, 2014 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424879
13.
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists.
Clin Genitourin Cancer
; 22(4): 102103, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38781786
14.
A phase I trial of enzalutamide plus selective glucocorticoid receptor modulator relacorilant in patients with metastatic castration resistant prostate cancer.
Clin Cancer Res
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536082
15.
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer.
Mol Cancer Ther
; 23(4): 552-563, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030378
16.
Bladder-Preserving Trimodality Therapy With Capecitabine.
Clin Genitourin Cancer
; 22(2): 476-482.e1, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228414
17.
Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.
Eur Urol Oncol
; 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072761
18.
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.
Cancer Lett
; 565: 216209, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169162
19.
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer.
Clin Cancer Res
; 29(10): 1929-1937, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897758
20.
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES.
Eur Urol
; 84(2): 229-241, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179240